Designing spatial and temporal control of vaccine responses

Abstract

Vaccines are the key technology to combat existing and emerging infectious diseases. However, increasing the potency, quality and durability of the vaccine response remains a challenge. As our knowledge of the immune system deepens, it becomes clear that vaccine components must be in the right place at the right time to orchestrate a potent and durable response. Material platforms, such as nanoparticles, hydrogels and microneedles, can be engineered to spatially and temporally control the interactions of vaccine components with immune cells. Materials-based vaccination strategies can augment the immune response by improving innate immune cell activation, creating local inflammatory niches, targeting lymph node delivery and controlling the time frame of vaccine delivery, with the goal of inducing enhanced memory immunity to protect against future infections. In this Review, we highlight the biological mechanisms underlying strong humoral and cell-mediated immune responses and explore materials design strategies to manipulate and control these mechanisms.

Methodological Approaches To Assess Innate Immunity and Innate Memory in Marine Invertebrates and Humans

“…High-throughput/high-content screening (HTS/HCS) assays and instruments can also help in assessing the immunotoxic effects of several agents in terms of changes in multiple cell parameters. Several of these HTS/HCS technologies (such as CyTOF, O-link, CITE-seq, Opera Phenix) are currently applied to clinical trials and vaccine efficacy studies, and will soon be applied to drug discovery and toxicology ( Pulendran and Davis, 2020 ; Arunachalam et al, 2021 ; Roth et al, 2021 ; Zielinski et al, 2021 ).…”

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases

“…Protein nanoparticles (NPs) can help in the development of vaccines for immuno-evasive pathogens such as HIV, influenza, malaria, and can aid in the fight against emerging virulent strains by either acting alone or acting as carriers for targeted drug delivery ( Hong et al, 2020 ; Roth et al, 2021 ). The engineering of protein molecules for antigen representation with the aid of NPs to be used in vaccine development for generating immune response is an increasingly popular and rapid field in therapeutic and drug development ( Jain et al, 2018 ).…”

Engineering optimal vaccination strategies: effects of physical properties of the delivery system on functions

“…36 The differentiation and maturation of T cells mainly occurs in the paracortex (T cell zone), where CD8 + T cells are primed in the central paracortex and CD4 + T cells in the peripheral paracortex; 37 the follicles (B cell zones) provide specific areas for B cell maturation. 38,39 Activated APCs present antigens to naïve T cells via MHC molecules. Naïve T cells differentiate into different types of effector T cells, including Th1, Th2, Th17, T-regulatory cells (Treg) and cytotoxic T lymphocyte (CTL).…”